(Q41441905)

30 September 2017

1 reference

title

Attention deficit hyperactivity disorder in the presence of Tourette syndrome (English)

1 reference

attention deficit hyperactivity disorder

30 September 2017

main subject

1 reference

Freeman RD

1

1 reference

30 September 2017

publication date

1 May 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

15

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

411-420

1 reference

Sleep disorders in Tourette syndrome: a primary or unrelated problem?

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Pemoline-induced Tourette's disorder: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Limitations of the Application of Fourfold Table Analysis to Hospital Data

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Methylphenidate-induced Tourette syndrome: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Comorbidity in Child Psychopathology: Concepts, Issues and Research Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

A prospective longitudinal study of Gilles de la Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

The Clinical Features of Tourette's Disorder: An Australian Study Using a Structured Interview Schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clonidine ameliorates Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Pharmacotherapy of Tourette's syndrome and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clonidine in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Role of genetic factors in human sexual behavior based on studies of Tourette syndrome and ADHD probands and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tourette Syndrome: A Hereditary Neuropsychiatric Spectrum Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Role of genetic factors in depression based on studies of Tourette syndrome and ADHD probands and their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tourette's Syndrome and Attention Deficit Disorder with Hyper activity: Are They Genetically Related?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tics following methylphenidate administration. A report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Auditory Evoked Potentials in Gilles de la Tourette Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Gilles de la Tourette's syndrome: effects of stimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Gilles de la Tourette's syndrome following methylphenidate administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

The effect of central nervous system stimulants on tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

The relationship between stimulant medication and tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Effects and noneffects of methylphenidate in children with mental retardation and ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

The treatment of sleep disorders with melatonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Deprenyl in attention deficit associated with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Bilineal transmission and phenotypic variation of Tourette's disorder in a large pedigree

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Obsessive-compulsive symptoms following stimulants.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Predictors of clonidine response in Tourette syndrome: implications and inferences

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Genetic mechanisms in childhood psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Gilles de la Tourette's disorder associated with pemoline

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Psychiatric comorbidity in patients with attention deficit disorder: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Observations and ratings of tics in school settings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

The early course of the Tourette's syndrome clinical spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Pemoline-induced abnormal involuntary movements

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clinical management of Tourette's syndrome and associated disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tricyclic antidepressant treatment of children with ADHD and tic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Tourette syndrome: issues in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970322-4

7 January 2021

10.1016/S0733-8619(05)70322-4

Identifiers

DOI

1 reference

30 September 2017

1 reference